Bilirubin Fractionation Guidelines

Introduction to Bilirubin Fractionation

The American Gastroenterological Association recommends ordering a laboratory test that measures total bilirubin and direct (conjugated) bilirubin, then calculating indirect (unconjugated) bilirubin by subtracting direct from total bilirubin, to guide differential diagnosis 1, 2

The European Association for the Study of the Liver recommends fractionating total bilirubin whenever it is elevated to determine the percentage derived from direct (conjugated) bilirubin, as this helps in diagnosing cholestatic liver disease 1, 2
Direct bilirubin includes both conjugated bilirubin and delta bilirubin, which has a half-life of approximately 21 days and causes prolonged hyperbilirubinemia, according to the American Association for the Study of Liver Diseases 3
The terms "direct" and "conjugated" are incorrectly used interchangeably in clinical practice, which can lead to misdiagnosis, as stated by the American Gastroenterological Association 3
If prolonged hyperbilirubinemia is unexplained, consider requesting breakdown of direct bilirubin into conjugated and delta fractions, as recommended by the European Association for the Study of the Liver 3

Conjugated (direct) bilirubin >35% of total typically indicates drug-induced liver injury (DILI) or hepatobiliary disease, according to the American Association for the Study of Liver Diseases 3
Unconjugated bilirubin <20-30% of total in the absence of hemolysis confirms Gilbert's syndrome, as stated by the American Gastroenterological Association 3

Gilbert's syndrome causes unconjugated hyperbilirubinemia with reduced glucuronyltransferase activity to 20-30% of normal, and total bilirubin rarely exceeds 4-5 mg/dL, according to the American Association for the Study of Liver Diseases 3
Confirm diagnosis by calculating conjugated bilirubin <20-30% of total in the absence of hemolysis, as recommended by the European Association for the Study of the Liver 3
Consider genetic testing for DNA mutations of UDP-glucuronosyltransferase if diagnosis remains uncertain, as stated by the American Gastroenterological Association 3
Monitor any persistent isolated elevations in direct bilirubin closely, especially in patients with underlying cholestatic liver disease, as this may indicate DILI even without aminotransferase elevation, according to the American Association for the Study of Liver Diseases 3

Unconjugated bilirubin is transported to the liver bound to albumin due to its lipophilic nature, and cannot be directly excreted, requiring hepatic processing 4
Conjugated bilirubin is created in hepatocytes through glucuronidation by the enzyme glucuronyltransferase, and can be excreted into bile and ultimately eliminated 4

Haemolysis from conditions like sickle cell disease, thalassemia, hereditary spherocytosis, or G6PD deficiency can cause unconjugated hyperbilirubinemia 5
Impaired conjugation, most commonly from Gilbert's syndrome, can also cause unconjugated hyperbilirubinemia, with reduced glucuronyltransferase activity to 20-30% of normal 6, 7
Parenchymal liver disease, including hepatitis, cirrhosis, and autoimmune conditions, and biliary obstruction from choledocholithiasis, cholangitis, or malignancy can cause conjugated hyperbilirubinemia 4, 5

The American Gastroenterological Association recommends that most laboratories report total bilirubin, which is the sum of conjugated and unconjugated fractions 4
When predominantly unconjugated elevation occurs without haemolysis, Gilbert's syndrome is virtually always the cause, according to the European Association for the Study of the Liver 4, 8
Direct bilirubin includes conjugated bilirubin plus delta bilirubin, which causes prolonged hyperbilirubinemia, as noted by the American Association for the Study of Liver Diseases 6, 7

In the neonatal period, physiological unconjugated hyperbilirubinemia is normal, but conjugated bilirubin >25 μmol/L requires urgent paediatric referral for possible liver disease, as recommended by the American Academy of Pediatrics 4, 8
In adults, the conjugated fraction should predominate even in significant liver disease, according to the American College of Gastroenterology 4, 8

The American College of Radiology distinguishes unconjugated (nonobstructive) hyperbilirubinemia—seen in hepatitis/sepsis, alcoholic liver disease, drug-induced liver disease—from conjugated (obstructive) hyperbilirubinemia—seen in common bile duct obstruction from stones or tumor 9, 10, 11